People

Carl Bjartmar

augustinetx.com

Carl Bjartmar, MD, PhD, was appointed Chief Medical Officer of Augustine Therapeutics in September2024 and remains named as CMO in the company’s2025 public posts, although he is absent from its current visible website leadership roster. His career includes clinical development at Ascelia Pharma and Wilson Therapeutics, including late-stage rare-disease programmes, and senior roles with Sanofi, Genzyme and Lundbeck. He earned medical and neuroscience doctoral degrees at Linköping University. This dated affiliation is qualified rather than assumed present executive employment.